August 01, 2022
5 min watch
Save
VIDEO: ‘Hypothesis-generating’ study results presented at ASCO
Video Player is loading.
Current Time 0:00Duration 0:00Stream Type LIVERemaining Time 0:00
Hossein Borghaei, DO, MS, spoke with Healio about findings from the S1800A Lung-MAP substudy and CheckMate 816.
Both studies were presented at ASCO Annual Meeting.
“I don’t think anything was necessarily practice-changing, but [it was] hypothesis-generating and also telling us to look for larger randomized studies to come,” Borghaei, chief of thoracic medical oncology, professor of hematology/oncology, co-director of the Immune Monitoring Facility and Gloria and Edmund M. Dunn chair in thoracic oncology at Fox Chase Cancer Center, said.
References:
- Provencio-Pulla M, et al. Abstract LBA8511. Presented at: ASCO Annual Meeting; June 3-7, 2022; Chicago.
- Reckamp KL, et al. Abstract 9004. Presented at: ASCO Annual Meeting; June 3-7, 2022; Chicago.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Borghaei reports serving as a consultant and/or advisory board member for Bristol Myers Squibb, Eli Lilly and Merck.